Adel S El-Azab

15PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Biomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 24, 2026
Discovery of thieno[2,3-d]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and in vivo validation in a breast cancer model.

|Jan 07, 2025
Remarkable utilization of quinazoline-based homosulfonamide for in vitro cytotoxic effects with triple kinase inhibition activities: cell cycle analysis and molecular docking profile.

Adel S El-Azab, Alaa A-M Abdel-Aziz, Ahmed H Bakheit

|Aug 21, 2024
S-Alkylated quinazolin-4(3H)-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study.

Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali

|Jul 15, 2024
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis.

Alaa A-M Abdel-Aziz, Adel S El-Azab, Simone Brogi

|Jan 08, 2023
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study.

Mohamed M Hefnawy, Mohammed M Alanazi, Abdullah M Al-Hossaini

|Nov 26, 2022
Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked Benzenesulfonamide.

Adel S El-Azab, Alaa A-M Abdel-Aziz, Hazem A Ghabbour

Pageof 3

Frequent Collaborators

14 joint publications

Alaa A-M Abdel-Aziz

5 joint publications

Magda A-A El-Sayed

4 joint publications

Hamad M Alkahtani

3 joint publications

Claudiu T Supuran